Related Experiment Video
Updated: Jan 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association Between Longitudinal Changes in Cardio-Ankle Vascular Index and Aortic Stenosis Progression in Dialysis
Shunsuke Todani1,2, Kazuhiro Shimizu2, Shuji Sato2
1Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, JPN.
Insights
In dialysis patients, a declining cardio-ankle vascular index (CAVI) signals worsening aortic stenosis (AS). Serial CAVI monitoring can help predict severe AS and guide valve replacement timing when echocardiography is unclear.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Vascular Biology
Background:
- Echocardiography often underestimates aortic stenosis (AS) progression in dialysis patients due to blood pressure variability and calcification.
- The cardio-ankle vascular index (CAVI), a blood pressure-independent measure of arterial stiffness, may offer a more reliable assessment.
- Predicting severe AS progression and optimizing valve replacement timing are critical in this high-risk population.
Purpose of the Study:
- To evaluate if serial changes in CAVI can anticipate severe AS progression in maintenance dialysis patients.
- To determine if CAVI can guide the timing of aortic valve replacement (AVR/TAVR) when echocardiographic findings are ambiguous.
Main Methods:
- Retrospective analysis of 1,169 maintenance dialysis patients, focusing on 41 who underwent AVR/TAVR.
- CAVI measurements were taken at four time points: 2 years, 1 year, and immediately before AVR/TAVR, and 1 year after.
- Severe AS progression defined as mean pressure gradient (meanPG) ≥ 40 mmHg; multivariable logistic regression identified progression determinants.
Main Results:
- Median CAVI declined significantly in the two years preceding AVR/TAVR (p < 0.001) and normalized post-procedure (p < 0.001).
- A greater CAVI decline (ΔCAVI) was associated with progression to severe AS (p = 0.022).
- ΔCAVI was the sole independent predictor of severe AS progression (OR 0.51 per 1-unit decrease; p = 0.013).
Conclusions:
- A significant preoperative decline in CAVI nearly doubles the risk of emergent severe AS in dialysis patients.
- Serial CAVI monitoring is a simple, noninvasive tool that may provide an early warning for severe AS.
- CAVI monitoring could help optimize intervention timing in dialysis patients with ambiguous echocardiographic results.
Abstract:
Objective In dialysis patients, echocardiography often underestimates the progression of aortic stenosis (AS) due to blood pressure fluctuations and extensive calcification that obscure standard indices. We evaluated whether serial changes in the cardio-ankle vascular index (CAVI), a blood pressure-independent marker of arterial stiffness, can anticipate severe AS and guide the timing of valve replacement. Methods This single-center, retrospective study screened 1,169 maintenance dialysis patients (2015-2023). Forty-one patients who underwent surgical or transcatheter aortic valve replacement (AVR/TAVR) had valid CAVI measurements at four time points: 2 years and 1 year before surgery, immediately before surgery, and 1 year after surgery. The -2-year time point served as the baseline. Hemodynamic, echocardiographic, and laboratory data were analyzed using the Friedman and Wilcoxon tests. Severe AS progression was defined as a new mean pressure gradient (meanPG) ≥ 40 mmHg. Determinants of progression were identified using multivariable logistic regression. Results Median CAVI declined from 10.2 to 9.4 over the two years preceding surgery (p < 0.001) and rose to 11.1 one year post-AVR/TAVR (p < 0.001). Simultaneously, ejection time increased, ejection fraction decreased, and Vmax, maxPG, stroke volume, and stroke volume index (SVi) all rose significantly (p < 0.01 for each), with no significant changes in blood pressure or heart rate. Patients who progressed to severe AS showed a greater CAVI decline (ΔCAVI -2.90 vs. -0.67; p = 0.022) and higher Vmax (4.0 vs. 3.0 m/s; p < 0.001). ΔCAVI was the only independent predictor of severe AS progression (OR 0.51 per 1-unit decrease; 95% CI: 0.20-0.89; p = 0.013). Age and sex were not significant. CAVI and peak PG showed a modest inverse correlation (ρ = -0.35). Conclusion In dialysis patients, a marked preoperative decline in CAVI nearly doubles the risk of emergent severe AS and normalizes after valve replacement, indicating true hemodynamic responsiveness. Serial CAVI monitoring, simple, noninvasive, and reproducible, may offer an early warning signal and help optimize intervention timing when echocardiographic findings are ambiguous.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Hemodialysis I: Introduction

